immunotherapychemoradiotherapystereotactic body radiotherapyosimertinibdurvalumabpembrolizumab
…h several novel cancer drugs such as osimertinib, alectinib and immunotherapy are not approved for use in advanced NSCLC. While this cost asy…
11articles mentioning treatments
31treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: chemoradiotherapy ×
chemoradiotherapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning chemoradiotherapy
11 articles · page 1 of 1ChemoradiotherapyNon-small cell lung cancerNSCLC[18F] FDGAmerican College of Radiology Imaging Network[18F]Fluorodeoxyglucose[18F]FDG[18F] fluorodeoxyglucoseCancer Imaging Archive
…anges in [18F] FDG uptake in other organs (figure 2).Conclusion Chemoradiotherapy has adverse effects on the vasculature, possibly through increa…
chemoradiotherapychemotherapyIMRTanal carcinomaYorkshire & The Humber – Bradford Leeds Research Ethics CommitteeACT5anal tumours
…removed anal tumours with margins ≤1 mm will receive lower dose chemoradiotherapy, while participants with anal tumours with margins >1 mm will b…
chemoradiotherapypembrolizumabatezolizumabdurvalumabNSCLCnon-small cell lung cancerosimertinibstage II-III NSCLC
…durvalumab and pembrolizumab and consolidation durvalumab after chemoradiotherapy. The study employed 1-month simulation cycles over a lifetime. …
neoadjuvant treatmentchemoradiotherapyconsolidation therapyadjuvant therapyneoadjuvant therapysurgeryAstraZenecastage I-IIIB NSCLCNSCLC
…ssion was used to assess the association of MDT discussion with neoadjuvant treatment.Results Baseline characteristics are summarized in table 1. Ove…
chemoradiotherapyNasopharyngeal carcinomaCochrane LibraryProQuestWan FangChina National Knowledge InfrastructurePubMedChinese Biomedical Literature DatabaseWeb of ScienceMEDLINE+2 more
…) presents significant nutritional challenges during concurrent chemoradiotherapy, adversely affecting treatment outcomes and quality of life. No…
chemoradiotherapythoracic malignanciesstage IA lung adenocarcinoma
…ecurrence involving the sympathetic chain. Following concurrent chemoradiotherapy, pain improved and the patient returned to work. Posture-depend…
90.8%
chemoradiotherapyneoadjuvant chemotherapymultimodality therapyimmunotherapyadjuvant chemotherapybrachytherapyPeCa
…ase II study by Ottenhof et al evaluated 33 patients undergoing chemoradiotherapy as primary treatment for locoregionally advanced PeCa. They rep…
chemoradiotherapyradiotherapyCervical CancerCaCxCharlotte Maxeke Johannesburg Academic HospitalUniversity of the WitwatersrandCMJAH-CCCHIV
…South Africa, often presenting at advanced stages and requiring chemoradiotherapy. In South Africa, the burden is disproportionately high among w…
chemoradiotherapyAnti-Hu antibody encephalitissmall cell lung cancermethyl prednisolonerituximabanti-Hu encephalitisintravenous immunoglobinstatus epilepticus
…and anti-Hu antibody positivity. She was treated initially with chemoradiotherapy leading to cancer remission but progression of her neurological…
multi-ion therapychemoradiotherapyradiotherapyhead and neck cancerNon-squamous cell carcinomasNational Institutes for Quantum Science and Technology Certified Review Board
…wed up according to the protocol for 180 days after the initial multi-ion therapy irradiation.Ethics and dissemination The study protocol has bee…